BAX326
251101
Phase 3 mab completed
Quick answer
BAX326 for Hemophilia B is a Phase 3 program (mab) at Takeda Pharmaceuticals International AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda Pharmaceuticals International AG
- Indication
- Hemophilia B
- Phase
- Phase 3
- Modality
- mab
- Status
- completed